RadNet, Inc. Q1 2011 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2011. RadNet, Inc. operates 201 diagnostic imaging facilities across six states (California, Maryland, Florida, Delaware, New Jersey, and New York). The company provides MRI, CT, PET, nuclear medicine, mammography, and other imaging services. Operations are reported as a single segment.
Key Financial Metrics
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Revenue | $146.2 million | $124.2 million |
| Net Loss (Attributable to Common Stockholders) | $(0.9) million | $(4.1) million |
| Net Loss Per Share (Basic & Diluted) | $(0.02) | $(0.11) |
| Operating Income | $8.2 million | $4.4 million |
| Adjusted EBITDA | $25.7 million | $20.5 million |
| Cash Flow from Operations | $15.2 million | $16.6 million |
| Cash and Cash Equivalents (End of Period) | $0.3 million | $0.0 million |
| Total Debt (Notes Payable + Line of Credit) | $496.0 million | N/A |
| Working Capital | $11.0 million | $5.8 million (Dec 31, 2010) |
Note: Total debt includes $200 million in senior notes, $282.2 million in term loans, and $15.9 million drawn on the revolving credit facility.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 17.8% year-over-year. Organic growth (same-store basis) was 2.7%, driven by procedure volume increases. Acquired centers contributed an additional $19.1 million in revenue.
- Profitability Improvement: Net loss attributable to common stockholders narrowed significantly from $4.1 million to $0.9 million. Operating margin improved from 3.5% to 5.6% of revenue.
- Expense Increases: Cost of operations rose 17.4% to $115.8 million, primarily due to salaries and professional reading fees associated with new acquisitions. Interest expense increased 29.6% to $12.9 million due to higher debt levels following the April 2010 refinancing.
- Other Income: The company recorded $1.9 million in other income, including $1.4 million from fair value adjustments on interest rate swaps and $0.5 million in insurance proceeds for equipment damaged in a fire.
Outlook, Risks, and Unusual Items
- Acquisitions: The company completed three acquisitions in Q1 2011 (Imaging On Call, Stuart London MD practice, Team Radiology) and one subsequent to quarter-end (five Maryland centers from Diagnostic Health Corp).
- Regulatory Risks: Management highlights significant uncertainty regarding Medicare reimbursement rates. While Congress passed temporary relief extending a 2.2% update through 2011, future statutory reductions remain a risk if Congress does not intervene.
- Liquidity: The company maintains a $100 million revolving credit facility with $15.9 million drawn. Management believes cash flow from operations and available borrowings are adequate for short- and long-term needs.
- Derivatives: Interest rate swaps are no longer designated as cash flow hedges following the 2010 refinancing. Changes in their fair value are recognized in earnings, contributing to the "Other Income" line item.
Investor Verification Checklist
- Debt Covenants: Verify compliance with debt covenants given the high leverage ratio and equity deficit of $81.8 million.
- Medicare Policy: Monitor Congressional action on the Medicare Physician Fee Schedule to assess potential revenue impacts in 2012.
- Acquisition Integration: Review the financial performance of recently acquired centers (Imaging On Call, Maryland facilities) to ensure they meet projected returns.
- Cash Position: Note the low cash balance ($0.3 million) and reliance on the revolving credit facility for liquidity.
- Bad Debt Provision: Analyze the provision for bad debts ($7.9 million, 5.4% of revenue) for trends in payer collections.